Skip to main content

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 1323 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bleyer WA, O’Leary M, Barr R, Ries LAG (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD

    Google Scholar 

  2. McMahon B (1957) Epidemiological evidence on the nature of Hodgkin Disease. Cancer 10:1045–1054

    Article  Google Scholar 

  3. O’Leary M, Sheaffer JW, Keller FG, et al (2006) Lymphomas and reticuloendothelial neoplasms. In: Bleyer WA, O’Leary M, Barr R, Ries LAG (eds) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD

    Google Scholar 

  4. Mueller NE, Grufferman S (1999) The epidemiology of Hodgkin Disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM (eds) Hodgkin Disease. Lippincott Williams & Wilkins, Philadelphia, pp 61–78

    Google Scholar 

  5. Sleckman BG, Mauch PM, Ambinder RF, et al (1998) Epstein-Barr virus in Hodgkin disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 7:1117–1121

    PubMed  CAS  Google Scholar 

  6. Glaser SL, Lin RJ, Stewart SL, et al (1997) Epstein-Barr virus-associated Hodgkin disease: epidemiologic characteristics in international data. Int J Cancer 70:375–382

    Article  PubMed  CAS  Google Scholar 

  7. Chang ET, Montgomery SM, Richiardi L, et al (2004) Number of siblings and risk of Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13:1236–1243

    PubMed  Google Scholar 

  8. Chang ET, Zheng T, Weir EG, et al (2004) Childhood social environment and Hodgkin lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370

    PubMed  Google Scholar 

  9. Ambinder RF, Weiss LM (1999) Association of Epstein-Barr virus with Hodgkin disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM (eds) Hodgkin Disease. Lippincott Williams & Wilkins, Philadelphia, pp 79–100

    Google Scholar 

  10. Henderson BE, Dworsky R, Pike MC, et al (1979) Risk factors for nodular sclerosis and other types of Hodgkin Disease. Cancer Res 39:4507–4511

    PubMed  CAS  Google Scholar 

  11. Jarrett RF (2003) Risk factors for Hodgkin lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin lymphoma. Leuk Lymphoma 44:S27–32

    Article  PubMed  CAS  Google Scholar 

  12. Hjalgrim H, Askling J, Rostgaard K, et al (2003) Characteristics of Hodgkin lymphoma after infectious mononucleosis. N Engl J Med 349:1324–1332

    Article  PubMed  CAS  Google Scholar 

  13. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337

    Article  PubMed  CAS  Google Scholar 

  14. Goldin LR, Pfeiffer RM, Gridley G, et al (2004) Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100:1902–1908

    Article  PubMed  Google Scholar 

  15. Mack TM, Cozen W, Shibata DK, et al (1995) Concordance for Hodgkin disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332:413–418

    Article  PubMed  CAS  Google Scholar 

  16. Staratschek-Jox A, Shugart YY, Strom SS, et al (2002) Genetic susceptibility to Hodgkin lymphoma and to secondary cancer: workshop report. Ann Oncol 13:30–33

    PubMed  Google Scholar 

  17. Calza L, Manfredi R, Colangeli V, et al (2003) Hodgkin disease in the setting of human immunodeficiency virus infection. Scand J Infect Dis 35:136–141

    Article  PubMed  Google Scholar 

  18. Westergaard T, Melbye M, Pedersen JB, et al (1997) Birth order, sibship size and risk of Hodgkin disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 72:977–981

    Article  PubMed  CAS  Google Scholar 

  19. Harris NL (1999) Hodgkin lymphomas: classification, diagnosis, and grading. Semin Hematol 36:220–232

    PubMed  CAS  Google Scholar 

  20. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International Classification of Childhood Cancer, third edition. Cancer 103:1457–1467

    Article  PubMed  Google Scholar 

  21. Landman-Parker J, Pacquement H, Leblanc T, et al (2000) Localized childhood Hodgkin disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy — results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol 18:1500–1507

    PubMed  CAS  Google Scholar 

  22. Lobo-Sanahuja F, Garcia I, Barrantes JC, et al (1994) Pediatric Hodgkin disease in Costa Rica: twelve years experience of primary treatment by chemotherapy alone, without staging laparotomy. Med Pediatr Oncol 22:398–403

    Article  PubMed  CAS  Google Scholar 

  23. Smith M, Gurney J, Ries L (1999) Cancer among adolescents 15–19 years old. In: Ries LAG (ed) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. National Cancer Institute, Bethesda, MD, pp 157–164

    Google Scholar 

  24. Selby P, Pate P, Milan S, et al (1990) ChlVPP combination chemotherapy for Hodgkin disease: long-term results. Br J Cancer 62:279–285

    PubMed  CAS  Google Scholar 

  25. Nachman JB, Sposto R, Herzog P, et al (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765–3771

    Article  PubMed  Google Scholar 

  26. Laskar S, Gupta T, Vimal S, et al (2004) Consolidation radiation after complete remission in Hodgkin disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol 22:62–68

    Article  PubMed  CAS  Google Scholar 

  27. Donaldson SS, Hudson MM, Lamborn KR, et al (2002) VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin disease: results of a prospective clinical trial. J Clin Oncol 20:3081–3087

    Article  PubMed  CAS  Google Scholar 

  28. Schellong G, Potter R, Bramswig J, et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin Disease Study Group. J Clin Oncol 17:3736–3744

    PubMed  CAS  Google Scholar 

  29. Yung L, Smith P, Hancock BW, et al (2004) Long-term outcome in adolescents with Hodgkin lymphoma: poor results using regimens designed for adults. Leuk Lymphoma 45:1579–1585

    Article  PubMed  CAS  Google Scholar 

  30. Ng AK, Bernardo MVP, Weller E, et al (2002) Second malignancy after Hodgkin Disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100:1989–1996

    Article  PubMed  CAS  Google Scholar 

  31. Hancock SL, Donaldson SS, Hoppe RT (1993) Cardiac disease following treatment of Hodgkin disease in children and adolescents. J Clin Oncol 11:1208–1215

    PubMed  CAS  Google Scholar 

  32. Bhatia S, Yasui Y, Robison LL, et al (2003) High risk of subsequent neoplasms continues with extended followup of childhood Hodgkin disease: report from the Late Effects Study Group. J Clin Oncol 21:4386–4394

    Article  PubMed  Google Scholar 

  33. Herbertson R, Hancock BW (2005) Hodgkin lymphoma in adolescents. Cancer Treatment Rev 31:339–360

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Trippett, T.M., Mottl, A., Oberlin, O., Bleyer, A., Constine, L.S. (2007). Hodgkin Lymphoma. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68152-6_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40842-0

  • Online ISBN: 978-3-540-68152-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics